COMMUNIQUÉS West-GlobeNewswire

Pluristem and U.S. Department of Defense to Announce Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome at RITN
17/07/2019
Data will be jointly presented at the upcoming 2019 Radiation Injury Treatment Network (RITN) Workshop on July 31st HAIFA, Israel, July 17, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc . (Nasdaq:PSTI) (TASE:PSTI [...]
Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy
17/07/2019
-- Conference Call Today at 1 PM ET/10 AM PT -- LOS ANGELES, July 17, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR) announced positive results from its interim analysis in the HOPE-2 Trial on [...]
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry
17/07/2019
San Diego, CA, July 17, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced that it has received a patent from the Patents Registry in Hong Kong (Hong Kong [...]
Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline
17/07/2019
ANN ARBOR, Mich., July 17, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced it has initiated the development of a [...]
RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint stock company “Grindeks” held on 17 July 2019
17/07/2019
1. Distribution of the company profit To pay EUR 12 268 800 or EUR 1,28 (one euro twenty-eight cents) per one share from accumulated profit till December 31, 2017 of joint stock company “Grindeks” to shareholders of [...]
Immuron to Host Investor Webinar on July 18 to Provide Update on Recent Developments
17/07/2019
MELBOURNE, Australia, July 17, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company, announced today that it will participate in an investor webinar and Q&A [...]
Immuron Prices Underwritten Public Offering of ADSs
17/07/2019
MELBOURNE, Australia, July 17, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
MVZ Prof. Dr. Uhlenbrock and Partner decides for C-RAD’s innovative SIGRT solution
17/07/2019
C-RAD announced today an order for its surface tracking solution based on Catalyst HD™ and Sentinel 4DCT™ for MVZ Prof. Dr. Uhlenbrock and Partner GmbH in Dortmund Germany. MVZ Uhlenbrock & Partner GmbH is a [...]
Orion Group Half-Year Financial Report January–June 2019
17/07/2019
ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY–JUNE 2019 17 JULY 2019 at 12.00 EEST Orion Group Half-Year Financial Report January–June 2019 Net sales in January–June 2019 totalled EUR 493 million (EUR 493 million [...]
Orion Corporation's financial reporting and Annual General Meeting in 2020
17/07/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 17 JULY 2019 at 11.00 a.m. EEST Orion Corporation's financial reporting and Annual General Meeting in 2020 Orion Corporation will publish its Financial Statement Release 2019 on [...]
AgraFlora Organics Expands Cannabinoid-Infused Cosmetics/Topicals Distribution to Continental US; Whole Hemp Health Personal Care Line Now Available in 20+ Brick and Mortar Locations Across Canada
17/07/2019
VANCOUVER, British Columbia, July 17, 2019 (GLOBE NEWSWIRE) -- Vancouver, British Columbia / July 17 th , 2019 – AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) ( [...]
Notice of extra general meeting in Acarix AB
17/07/2019
Press release July 17, 2019 Notice of extra general meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the " Company "), are hereby convened to the extra general meeting to be held on Friday 16 [...]
Nicox: Second Quarter 2019 Business Update and Financial Highlights
17/07/2019
Press Release Nicox: Second Quarter 2019 Business Update and Financial Highlights Enrollment completed in the NCX 470 Phase 2 clinical trial in patients with glaucoma and ocular hypertension with results expected in [...]
Nicox : Point d’activité et résumé financier du deuxième trimestre 2019
17/07/2019
Communiqué de presse Nicox : Point d’activité et résumé financier du deuxième trimestre 2019 Recrutement terminé dans l’étude clinique de phase 2 sur le NCX 470 pour le glaucome et l’hypertension oculaire. Premiers [...]
Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF
17/07/2019
Study expands potential clinical indications for lead compound Trial fully funded via a grant from the United States National Institutes of Health ARCHAMPS, France, July 17, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext [...]
Genkyotex annonce l'approbation par la FDA de l'essai de Phase 2 avec le GKT831 dans la fibrose pulmonaire
17/07/2019
Cette étude élargit les indications cliniques potentielles pour ce composé phare Essai financé par une subvention des National Institutes of Health aux États-Unis ARCHAMPS, France, 17 juill. 2019 (GLOBE NEWSWIRE) -- [...]
First Publication from OSE Immunotherapeutics on the Role of SIRPα in the Induction and Maintenance of Immune Tolerance in the American Journal of Transplantation
17/07/2019
Findings show the role of the SIRPα/CD47 axis in the maintenance of acquired immune tolerance Highlights the differentiated mechanism of action of OSE's innovative myeloid checkpoint inhibitor BI 765063 (OSE-172), a [...]
Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024
17/07/2019
WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the pricing of concurrent underwritten public offerings of 1,380,000 shares of its common stock (the “ [...]
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
17/07/2019
VANCOUVER, British Columbia, July 16, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Pages